Revvity Shares Hit $128.49 Amid High Valuation and Insider Selling

Revvity Inc shares rose 3.4% to $128.49, trading at a premium to historical averages while insiders continue to sell positions.
Revvity Inc (RVTY) shares climbed 3.4% on September 14, 2026, closing at $128.49. This move extends the stock’s one-year gain of 55.5%, placing it near the upper end of its 52-week range, which spans from $81.22 to $133.00. The price action reflects strong momentum, though it diverges significantly from the company’s historical valuation metrics.
Despite the recent surge, valuation data suggests the stock is trading at a premium. The current price is 9.4% above the estimated fair value of $117.48, indicating a limited margin of safety for new investors. This premium is supported by strong recent performance but raises questions about the sustainability of the price increase relative to fundamental earnings.
Valuation Metrics Exceed Historical Norms
Revvity’s trailing twelve-month price-to-earnings ratio stands at 61.2x, more than double its five-year median of 30.1x. This significant expansion in multiple indicates that the market is pricing in higher expectations for future earnings growth. The forward P/E ratio of 21.8x suggests that analysts expect earnings to accelerate, but the current premium requires sustained outperformance to justify the cost.
Financial Health and Growth Constraints
The company maintains a strong financial profile, with a composite health score of 77 out of 100. Sub-scores highlight strengths in momentum (9/10) and profitability (7/10), alongside a solid valuation rating (7/10). However, the growth component scores only 4/10, signaling potential limitations in the company’s ability to expand earnings rapidly. Financial strength remains robust at 6/10, providing a stable base for operations despite the slower growth trajectory.
Insider and Institutional Positioning
Insider activity presents a counter-signal to the recent price rise. Company insiders sold $4.7 million worth of shares over the past 12 months, with no corresponding purchases. Concurrently, five tracked institutional investors have trimmed their positions in recent quarters, with none adding to their stakes. This consistent reduction in holdings by parties with direct knowledge of the business suggests caution regarding the current valuation levels and future upside potential.






